Search clinical trials for: PMO

Total 49 results

Petrovsky National Research Centre of Surgery

Recruiting

Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients

Thoracic Aortic Aneurysm | Thoracic Aortic Dissection | Cardiac Valve Disease | Aortic Aneurysm and Dissection

Russian Federation
Vertex Pharmaceuticals Incorporated

Recruiting

A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) (Galileo)

Myotonic Dystrophy Type 1 (DM1)

United Kingdom, Canada, Australia
Dalarna County Council, Sweden
Uppsala University

Recruiting

Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD) (PMOD)

Mouth Neoplasms

Sweden
Central Hospital, Nancy, France

Recruiting

Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial (CANREO-PMO)

Brain-dead Organ Donors

France
German Cancer Research Center

Recruiting

CRAFT: The NCT-PMO-1602 Phase II Trial

Metastatic or Locally Advanced Malignancies

Germany
National Center for Tumor Diseases, Heidelberg
AstraZeneca; German Cancer Research Center; PharmaMar

Completed

Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors (NCT-PMO-1603)

Cancers With DNA Repair-Deficiency

Germany
German Cancer Research Center
German Consortium for Translational Cancer Research

Completed

Afatinib in Advanced NRG1-Rearranged Malignancies

Metastatic and Locally Advanced NRG1-rearranged Malignancies

Germany
Mabwell (Shanghai) Bioscience Co., Ltd.

Completed

Efficacy and Safety of MW031 in PMO Subjects

Osteoporosis, Postmenopausal

China
Regeneron Pharmaceuticals

Terminated

Efficacy and Safety of the Combination of Pozelimab and Cemdisiran Versus Continued Eculizumab or Ravulizumab Treatment in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (ACCESS 2)

Paroxysmal Nocturnal Hemoglobinuria

United States
Shanghai Henlius Biotech

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

Postmenopausal

China
Biocon Biologics UK Ltd

Active, not recruiting

Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis (DEVOTE)

Postmenopausal Women With Osteoporosis

United Kingdom
University Hospital Heidelberg

Completed

CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT-PMO-1601)

Chordoma

Germany
University Hospital, Tours

Completed

Comparison of Two Techniques of Renal Pre-transplant Infusion on the Evolution of Renal Function in the Recipient (RENOMAP)

Transplantation | Kidney

France
Hospital Clinic of Barcelona
University of Barcelona

Completed

Pharmacokinetic Model of Fibrinogen Plasma Levels After Fibrinogen Administration (PKMF)

Fibrinogen; Deficiency, Acquired | PHARMACOKINETICS

Spain
Robert Shulman, M.D.

Completed

Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain (PMO)

Abdominal Pain

United States
Ipsen

Completed

Dysport in Post-Surgical Neuralgia (PMOD03)

Chronic Scar Pain

United Kingdom
University of Florida
Chiesi Farmaceutici S.p.A.

Completed

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI (CANTIC)

Percutaneous Coronary Intervention | ST Segment Elevation Myocardial Infarction

United States
Steno Diabetes Center Copenhagen

Unknown

Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

Effect of Glucagon-like Peptide 2 on Gallbladder Motility

Denmark
The Medicines Company

Completed

Cangrelor to Clopidogrel or Prasugrel Transition Study (BRIDGE)

Coronary Artery Disease (CAD)

United States
Imperial College London
Sarepta Therapeutics, Inc.; Department of Health, United Kingdom

Completed

Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

United Kingdom
AbbVie

Terminated

A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA) (Treat & Train)

Axial Spondyloarthritis

Germany
AbbVie

Completed

Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients (HOPE)

Hidradenitis Suppurativa

Sweden
Amgen

Completed

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis (PMO)

Japan
Universitaire Ziekenhuizen KU Leuven

Completed

Effect of Pancreatic Polypeptide on Gastric Motor Function and Food Intake in Humans

Hunger

Belgium
AbbVie

Completed

Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients (AS PMOS)

Ankylosing Spondylitis
Second Affiliated Hospital of Soochow University

Unknown

The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP) (PMOP)

Postmenopausal Osteoporosis

China
xuhuijuan

Unknown

CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome (PMOP)

Postmenopausal Osteoporosis

China
Novartis Pharmaceuticals

Completed

A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years

Postmenopausal Osteoporosis

Turkey
AbbVie (prior sponsor, Abbott)

Completed

Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice (IDEA)

Ankylosing Spondylitis
AbbVie (prior sponsor, Abbott)

Completed

Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice (PACE)

Rheumatoid Arthritis
Hoffmann-La Roche

Completed

Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan

Postmenopausal Osteoporosis

Pakistan
OrthoCarolina Research Institute, Inc.
DJO Incorporated

Terminated

Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures

Pain | Patient Satisfaction | Wound Healing | Narcotic Consumption

United States
AbbVie (prior sponsor, Abbott)
University Health Network, Toronto

Completed

Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA (REACH)

Moderate-to-severe Rheumatoid Arthritis
Asan Medical Center
Korea Otsuka Pharmaceutical Co., Ltd.

Unknown

PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study (PICASSO-IMT)

Brain Ischemia | Intracranial Hemorrhages
Clinical Hospital Centre Zagreb
Merck Sharp & Dohme LLC

Completed

Natriuretic Effect of GLP-1in Healthy Non Obese Subjects

Sodium Excretion by Urination

Croatia
AbbVie (prior sponsor, Abbott)

Completed

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Psoriatic Arthritis | Ankylosing Spondylitis
AbbVie (prior sponsor, Abbott)

Completed

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Chronic Kidney Disease | Secondary Hyperparathyroidism

Bulgaria, Czech Republic, Romania
AbbVie (prior sponsor, Abbott)

Completed

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Moderate to Severe Plaque Psoriasis

Czech Republic, Estonia, Hungary, Israel, Romania, Slovakia, Slovenia, Ukraine
AbbVie (prior sponsor, Abbott)

Completed

A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

Rheumatoid Arthritis

Greece
Bagcilar Training and Research Hospital
Istanbul University

Completed

Effect of Bone on Vibration-Induced Muscle Electrical Activity (PMO-WBV-sEMG)

Osteoporosis

Turkey
Abbott

Completed

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection (INSPIRA)

Respiratory Syncytial Virus Infection

Peru
Abbott

Completed

Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer

Prostatic Neoplasm

Belgium, Luxembourg
Abbott

Completed

Drug Use Investigation of Kaletra

Human Immunodeficiency Virus

Japan
Abbott

Completed

Special Investigation of Kaletra in Pregnant Women

Human Immunodeficiency Virus

Japan
Abbott

Completed

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use (KaleEAST)

HIV-1 Patients

Czech Republic, Georgia, Israel, Latvia, Lithuania, Poland, Romania, Russian Federation, Serbia, Slovakia, Slovenia, Ukraine
Warner Chilcott
Sanofi

Completed

Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO

Postmenopausal Osteoporosis

Australia, Italy, Poland, Spain, Sweden
Medical University of Vienna
Polymun Scientific, Vienna, Austria

Completed

Recombinant Human Superoxide Dismutase (rhSOD) and Vascular Reactivity

Inflammation

Austria
Sanofi

Completed

Satisfaction and Compliance of Risedronate in PMO

Osteoporosis, Postmenopausal

Korea, Republic of
Institute for Clinical and Experimental Medicine
Ministry of Health, Czech Republic

Unknown

Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes

Diabetes Mellitus, Type 1

Czech Republic

3

Subscribe